Advanced Biomed Inc. Common Stock

ADVB

Medical - Diagnostics & Research · Healthcare

Price

$7.08

-1.82 (-20.45%)

Market Cap

$7.7M

Exchange

NASDAQ Global Select

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Advanced Biomed Inc. is a small biotechnology company focused on developing treatments for serious diseases, particularly cancer and neurological conditions. The company works on experimental therapies that are still in early research and clinical testing stages, meaning its products are not yet approved or sold to patients. It operates in the medical research and diagnostics industry, targeting healthcare providers and patients who need new treatment options.

The company currently generates little to no revenue, as it is in the development phase and has not brought any products to market yet. Advanced Biomed is a small-cap company, likely operating primarily in North America and Asia, and it funds its work through capital raises rather than product sales. The main risk the business faces is the long and expensive process of getting experimental drugs approved by regulators like the FDA, which requires successful clinical trials that are not guaranteed to succeed.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-967.4% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$28,341/ year

↓ Declining (-97% vs prior year)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

85.8%ownership

Insiders own a meaningful stake in the company

Cash Runway

5+ years

Quarterly Free Cash Flow

→ Burn rate stable

$3M cash & investments at current burn rate

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 1.1M (2021) → 1.1M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

—

Data not available

Operating Margin

N/A

—

Data not available

ROCE

-5.3%

Weak — -5.3% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.07

Conservative — low debt load (0.07)

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial